Drug Topics

SEPTEMBER 21, 2022

The risk could allow unauthorized users to change insulin levels.

FDA 247

FDA 247

NF2 BioSolutions

SEPTEMBER 21, 2022

We have been very busy organising the NF Community Day in Manchester with other NF organisations and in particular NF Patients United. Registration for the NF Community Day is now open from Sept 20th 2022! You MUST register & sign up via this link: [link]. There is a maximum of 100 registration places available. Location: Mercure Manchester Piccadilly Hotel, £5 Per person attending.

124

124

Pharmacy Times

SEPTEMBER 21, 2022

Drs Tom Lodise and Bincy Abraham provide an overview of fecal microbiota transplantation and long-term safety of FMT use.

123

123

STAT

SEPTEMBER 21, 2022

The short history of CRISPR gene editing in humans has, with rare exception, been a history of triumphant progress: A patient apparently cured of sickle cell in 2019, six patients with toxic DNA knocked out of their liver last year, another six patients with a different strand of toxic liver DNA knocked out last week.   The next era of CRISPR may not be so smooth.

117

117

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

SEPTEMBER 21, 2022

Nivolumab is a biomarker that has been shown to benefit the survival of patients with stage 2 melanoma patients compared with placebo.

123

123

pharmaphorum

SEPTEMBER 21, 2022

The European Commission has followed the lead of the US FDA and approved AstraZeneca’s Tezspire as an add-on maintenance therapy for patients with severe asthma, becoming the first and only biologic that can be used in all patients, and not restricted to those with specific forms of the disease. Tezspire (tezepelumab) has been cleared for use in patients 12 years and older with severe asthma who are inadequately controlled with high dose inhaled corticosteroids plus another medicinal produ

Labelling 111

Labelling FDA 111

STAT

SEPTEMBER 21, 2022

TORONTO — The Finks, married just a month earlier, sat down for their appointment, Kim dressed in head-to-toe pink and Chris in all black. He was taciturn, while she joked she couldn’t stop talking long enough to have her blood pressure taken. Jouvence Tshiyoyo Bukumba, a nurse, asked Kim, 46, about her cardiology appointment and Chris, 54, about his nerve pain.

109

109

Pharmacy Times

SEPTEMBER 21, 2022

Assess for medication-related problems, monitor patients remotely, and use mobile tools to deliver consultations.

121

121

Drug Store News

SEPTEMBER 21, 2022

Walmart plans to add 40,000 associates for the holiday season and beyond.

105

105

Pharmacy Times

SEPTEMBER 21, 2022

There are several important policy issues that could impact pharmacists’ ability to positively affect the quality of care for patients through the use of pharmacy performance measures.

114

114

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

SEPTEMBER 21, 2022

Researchers reported Wednesday that they could quickly and reliably turn CAR-T cells on and off in cancer patients, giving scientists an unprecedented level of control over this potent — but at times dangerous — oncology therapy. The findings, presented at the CAR-TCR Summit in Boston, come from an early-stage clinical trial by Scripps Research of patients with B cell cancers.

98

98

Drug Store News

SEPTEMBER 21, 2022

The cereal features creamy chocolate and lightly roasted peanut butter flavors with fudge-covered pieces, Kellogg’s said.

98

98

PharmExec

SEPTEMBER 21, 2022

A cookieless future is on the horizon, so marketers across all industries are being forced to rethink their strategies and plan for the future. What does that entail?

98

98

STAT

SEPTEMBER 21, 2022

Catalent, one of the largest contract manufacturers in the pharmaceutical industry, was cited by the U.S. Food and Drug Administration for a series of quality control failures at a facility in Bloomington, Ind., the same plant where the company helps produce two Covid-19 vaccines. The issues prompted the agency to delay distribution of Moderna booster shots, although their release has now reportedly been authorized.

Vaccines 98

Vaccines FDA 98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

SEPTEMBER 21, 2022

New book sets the pharmaceutical industry on a course for bridging the patient centricity optimism gap. Bridging the gulf between patient centricity ambition and reality has never been more important for pharma – luckily, this seemingly insurmountable goal isn’t as far out of reach as many envision. That’s according to Sharon Suchotliff, patient centricity lead at consultancy firm ZS Associates, which has just published a book on the art of patient involvement.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

Drug Store News

SEPTEMBER 21, 2022

Important personnel changes you should know this week.

96

96

The Guardian - Pharmaceutical Industry

SEPTEMBER 21, 2022

The Inflation Reduction Act aims to reduce the cost of drugs, but the law’s limitations may not help the Democrats in the midterms At a Labor Day speech in Milwaukee, Joe Biden declared nothing less than victory over the pharmaceutical industry. “We beat pharma!” Biden said, leaning into the microphone. “We beat pharma this year, and it mattered. We’re going to change people’s lives.

91

91

PharmExec

SEPTEMBER 21, 2022

With more people working from home, employers should rethink how cost-of-living impacts salary negotiations.

69

69

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

SEPTEMBER 21, 2022

Janssen’s GUIDE data demonstrate that patients treated with guselkumab less than 2 years after disease onset vs later are more likely to achieve “super-responder” at week 20 through 28.

65

65

pharmaphorum

SEPTEMBER 21, 2022

Takeda has decided that there is a future for its aurora kinase A inhibitor alisertib after it failed a phase 3 trial in lymphoma – but the company won’t be taking the drug forward itself. Enter Puma Biotech, which is paying a modest $7 million upfront for rights to alisertib (formerly MLN8237) and plans to run clinical trials of the compound in breast and lung cancers.

Chemotherapy 64

Chemotherapy Compounding 64

Pharma Times

SEPTEMBER 21, 2022

A new genetically engineered virus has delivered a one-two punch in initial phase 1 trial

63

63

Drug Store News

SEPTEMBER 21, 2022

The company is offering bortezomib for injection 3.5 mg and ulvestrant injection 250 mg/5ml.

59

59

Pharmaceutical Technology

SEPTEMBER 21, 2022

Rocket Pharmaceuticals has entered a definitive agreement for the acquisition of biotechnology firm Renovacor in an all-stock equity deal worth nearly $53m, or $2.60 for each share. Renovacor focuses on offering precision treatments for genetic cardiovascular and mechanistically-related ailments. The most advanced programme of the company is adeno-associated virus (AAV)-based gene therapy, REN-001.

59

59

InCrowd

SEPTEMBER 21, 2022

The 2022 Annual Meeting of the European Society for Medical Oncology (ESMO) took place in person from September 9th to the 13th. InCrowd wanted to learn from those Medical Oncologists and Hematology-Oncologists who attended the following two objectives: Explore which tumor type/track had the most exciting data presented Understand what attendees found exciting about the tumor type data presented.

52

52

BuzzRx

SEPTEMBER 21, 2022

Scrape on knees, minor cuts, animal bites, surgical incisions—wounds come in many shapes and sizes. Essentially, wounds are anything that break the skin. As soon as the skin is wounded, the body springs into action and starts the healing process. But how do you tell if a wound is healing properly? Please read on to learn some of the signs of healthy wound healing as well as an infected wound.

Immunization 52

Immunization 52

Pharmaceutical Commerce

SEPTEMBER 21, 2022

AZ’s Greg Rossi talks about the company’s oncology activities and his vision for the future of cancer treatment.

52

52

BuzzRx

SEPTEMBER 21, 2022

Edema is the medical term for swelling, which occurs due to the accumulation of fluid in the body's tissues. Edema is usually in the lower leg region, such as in the feet and ankles, but it can involve any body part. Certain medications can cause edema as a side effect. Please continue reading to find out which medications can cause swelling and how to treat it.

Chemotherapy 52

Chemotherapy 52

Pharmaceutical Technology

SEPTEMBER 21, 2022

Pfizer and CytoReason have expanded their multi-year collaboration to leverage the latter’s artificial intelligence (AI) technology to discover and develop the former’s drug programmes. According to the deal, Pfizer will invest $20m in equity, hold options for licencing the platform and disease models of CytoReason, and provide additional funding for supporting supplementary projects.

Immunization 52

Immunization 52

pharmaphorum

SEPTEMBER 21, 2022

Novartis is running out of options in its bid to defend oral muscular sclerosis therapy Gilenya from early generic competition in the US. The US Court of Appeals for the Federal Circuit (CAFC) has denied the Swiss pharma group’s petition to rehear its decision on the validity of US Patent No. 9,187,405, granted in 2015, which covers a specific dosing regimen for Gilenya (fingolimod) in relapsing-remitting MS.

52

52

Pharmaceutical Technology

SEPTEMBER 21, 2022

The proportion of pharmaceutical companies hiring for industrial automation related positions rose in August 2022 compared with the equivalent month last year, with 52% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 49.7% of companies who were hiring for industrial automation related jobs a year ago but a decrease compared to the figure of 58.3% in July 2022.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

The FDA Law Blog

SEPTEMBER 21, 2022

By McKenzie E. Cato — On August 9, 2022, the Secretary of the Department of Health and Human Services (HHS) declared the outbreak of monkeypox virus a public health emergency (see announcement here ). On September 7, 2022, the Secretary of HHS declared that “circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of infection with the monkeypox virus, including in vitro diagnostics that detect and/or diagnose infection with non-va

FDA 52

FDA Immunization 52

Pharma Times

SEPTEMBER 21, 2022

Tezspire is a maintenance therapy for patients with no phenotype or biomarker limitations

49

49

Pharmaceutical Commerce

SEPTEMBER 21, 2022

Will feature drug discovery, gene and RNA therapy technology.

40

40